Nu Skin (NUS) Showing Signs Of A Dead Cat Bounce Today

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified Nu Skin ( NUS) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Nu Skin as such a stock due to the following factors:

  • NUS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $89.1 million.
  • NUS has traded 148,569 shares today.
  • NUS is up 4.9% today.
  • NUS was down 5.1% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in NUS with the Ticky from Trade-Ideas. See the FREE profile for NUS NOW at Trade-Ideas

More details on NUS:

Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex brands. The stock currently has a dividend yield of 3.1%. NUS has a PE ratio of 8.9. Currently there are 2 analysts that rate Nu Skin a buy, 1 analyst rates it a sell, and 3 rate it a hold.

The average volume for Nu Skin has been 1.3 million shares per day over the past 30 days. Nu Skin has a market cap of $2.6 billion and is part of the consumer goods sector and consumer non-durables industry. The stock has a beta of 2.36 and a short float of 4.5% with 1.58 days to cover. Shares are down 67.7% year-to-date as of the close of trading on Friday.

If you liked this article you might like

Herbalife, Nu Skin May Be Affected by New Chinese Regulations

Birchbox Revolutionized How We Buy Beauty Products

Take a Fresh Look at Nu Skin Enterprises

Market Recon: Crossed Wires? Hot Wire, Trip Wire, Live Wire

Nu Skin (NUS) Stock Tumbles on Downbeat Forecast